Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test

• Published in: Journal of translational medicine Vol. 17; no. 1; pp. 347 - 14
• Main Authors: Peng, Zhen, Duan, Fujiao, Yin, Jingjing, Feng, Yajing, Yang, Zhongyu, Shang, Jia
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 22.10.2019; BioMed Central; BMC
• Subjects: Biological markers; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Cancer; Cancer genetics; Cancer patients; Cancer research; Carcinoma; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - metabolism; Carcinoma, Hepatocellular - mortality; Databases, Nucleic Acid; Disease-Free Survival; Family; Female; Gene expression; Health aspects; Hepatocellular carcinoma; Humans; Kaplan-Meier Estimate; Liver Neoplasms - genetics; Liver Neoplasms - metabolism; Liver Neoplasms - mortality; Male; Mediation; Medical research; MicroRNA; MicroRNAs - genetics; MicroRNAs - metabolism; miRNA-130a; miRNA-130b; Neoplasms - genetics; Neoplasms - metabolism; Neoplasms - mortality; Prognosis; Progression-Free Survival; Stomach Neoplasms - genetics; Stomach Neoplasms - metabolism; Stomach Neoplasms - mortality; Systematic evaluation; Transcriptome; Translational Research, Biomedical; China; miRNA-130b; Prognosis; miRNA-130a; Cancer; Systematic evaluation

Emerging evidence shows that microRNA-130 (miRNA-130) family may be useful as prognostic biomarkers in cancer. However, there is no confirmation in an independent validation study. The aim of this study was to summarize the prognostic value of miRNA-130 family (miRNA-130a and miRNA-130b) for surviva...